Standards for Evaluating Neonatal Growth Outcomes Using Individualized Pathological Growth Potential Realization Indices

Authors

Russell L Deter
Wesley Lee
Roberto Romero

Publication Date

12-1-2022

Journal

Journal of Maternal-Fetal and Neonatal Medicine

DOI

10.1080/14767058.2021.1958312

PMID

34470127

PMCID

PMC8885773

PubMedCentral® Posted Date

12-1-2023

PubMedCentral® Full Text Version

Author MSS

Published Open-Access

yes

Keywords

Female, Humans, Infant, Newborn, Pregnancy, Fetal Growth Retardation, Gestational Age, Pregnancy Trimester, Second, Reference Values, Ultrasonography, Prenatal

Abstract

OBJECTIVE: Provide standards for detecting neonatal growth abnormalities with the average pathological Growth Potential Realization Index (av. pGPRI).

METHODS: Individualized Growth Assessment (IGA) evaluations of 117 neonates with normal growth outcomes were carried out using measurements of WT, HC, AC, ThC and CHL. Growth Potential Realization Index (GPRI) values for each parameter were calculated from predicted and actual birth measurements, the former obtained using Rossavik size models derived from the second-trimester growth potential estimates. Subtraction of either the upper and lower boundaries of GPRI reference ranges from these GPRI measurements gave + pGPRI and - pGPRI measurements. GPRI's within their reference ranges were assigned pGPRI values of zero. Average values for these two types of pGPRI's were calculated for the WT, HC, CHL set (

RESULTS: The 95% reference ranges for the av. +pGPRI's and av. -pGPRI's in the WT, HC, CHL set were 0% to +0.50% and 0% to -0.40%, respectively. In the WT, HC, AC, ThC, CHL set, the comparable results were 0% to +0.50% and 0% to -0.72%.

CONCLUSION: Standards are provided for classifying neonatal growth outcomes with a parameter quantifying growth pathology that was based on individualized growth potentials.